At a glance
- Originator Pharmacia Corporation
- Class Antirheumatics; Bisphosphonates; Calcium regulators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 01 Jul 1999 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)